Evidence map›Paper›PMID 35485773›Full record

ArticleScandinavian journal of primary health care2022

Healthcare use in the year preceding a diagnosis of pancreatic cancer: a register-based cohort study in Denmark.

Linda A Rasmussen, Line F Virgilsen, Claus W Fristrup, Peter Vedsted, Henry Jensen

Open access · goldAbstract read
In one paragraph

Article in Scandinavian journal of primary health care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Prediagnostic prescription patterns in pancreatic cancer: a retrospective primary care cohort study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Linda A RasmussenResearch Unit for General Practice, Aarhus, Denmark.
Line F VirgilsenResearch Unit for General Practice, Aarhus, Denmark.
Claus W FristrupDepartment of Surgery, Odense Pancreas Centre (OPAC), Odense University Hospital, Odense, Denmark.
Peter VedstedResearch Unit for General Practice, Aarhus, Denmark.
Henry JensenResearch Unit for General Practice, Aarhus, Denmark.
Odense University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe the use of healthcare prior to a diagnosis of pancreatic cancer in Denmark.

designA population-based cohort study using prospectively recorded data from Danish National Health Registries.

settingDanish general practice and hospitals. SUBJECTS: A total of 5926 patients diagnosed with pancreatic cancer in 2012-2018 and 59,260 matched references without pancreatic cancer from the Danish general population.

main outcome measuresThe monthly frequency of healthcare use (contacts and tests in general practice and contacts and diagnostic investigations in hospitals) during the 12 months preceding the pancreatic cancer diagnosis and a corresponding index date assigned to the references.

resultsCompared to the references, the patients had increased contacts and diagnostic tests, especially blood glucose testing, in general practice from 7 to 12 months before diagnosis. Hospital contacts and diagnostic imaging increased from 5 months before the diagnosis.

conclusionsThe pattern of increasing healthcare contacts before a diagnosis of pancreatic cancer may represent a window of opportunity to diagnose pancreatic cancer earlier. The increased use of blood glucose test in general practice may represent an important sign of an underlying disease. Key pointsPancreatic cancer is a rapidly progressing and highly lethal disease. Focus on early diagnosis is essential to improve the prognosis.Patients with pancreatic cancer had increased number of healthcare contacts from 7 months before the diagnosis.Patients with pancreatic cancer had increased number of blood glucose tests taken throughout almost the entire year before the diagnosis.The results may indicate that a window of opportunity exists to diagnose pancreatic cancer earlier.

Indexed as

Blood GlucosePancreatic NeoplasmsCohort StudiesDelivery of Health CareDenmarkHumansRegistriesBlood GlucoseDenmarkearly detection of cancergeneral practicehealth services researchPancreatic neoplasms

Identifiers

PMID35485773
PMCPMC9397460
OpenAlexW4225128024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.